Targeting AFP-RARβ complex formation: a potential strategy for treating AFP-positive hepatocellular carcinoma-Reference-Cited by-同舟云学术

Targeting AFP-RARβ complex formation: a potential strategy for treating AFP-positive hepatocellular carcinoma

Published:2024-07-02 Issue: Volume: Page:
ISSN:1381-1991
Container-title:Molecular Diversity
language:en
Short-container-title:Mol Divers

Author:

Banjan Bhavya,Vishwakarma Riya,Ramakrishnan Krishnapriya,Dev Radul R.,Kalath Haritha,Kumar Pankaj,Soman Sowmya,Raju Rajesh,Revikumar Amjesh,Rehman Niyas,Abhinand Chandran S.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11030-024-10915-8.pdf

Reference88 articles.

1. Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 16(10):589–604. https://doi.org/10.1038/s41575-019-0186-y

2. Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D (2021) Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res 149:1–61. https://doi.org/10.1016/bs.acr.2020.10.001

3. Xu Y, Guo Q, Wei L (2021) The emerging influences of alpha-fetoprotein in the tumorigenesis and progression of hepatocellular carcinoma. Cancers (Basel) 13(20):5096. https://doi.org/10.3390/cancers13205096

4. Wei Z, Zhang Y, Lu H, Ying J, Zhao H, Cai J (2022) Serum alpha-fetoprotein as a predictive biomarker for tissue alpha-fetoprotein status and prognosis in patients with hepatocellular carcinoma. Transl Cancer Res 11(4):669–677. https://doi.org/10.21037/tcr-21-2334

5. Galle PR, Foerster F, Kudo M, Chan SL, Llovet JM, Qin S et al (2019) Biology and significance of alpha-fetoprotein in hepatocellular carcinoma. Liver Int 39(12):2214–2229. https://doi.org/10.1111/liv.14223